公开(公告)号：EP4400505A1

公开(公告)日：2024-07-17

申请号：EP22863643.7

申请日：2022-09-02

申请人： Bivision Pharmaceuticals, Inc

发明人： YU, Haihua ,  WANG, Eric Yanjun ,  WANG, Kevin Yu

IPC分类号： C07F13/00 ,  C07K5/037 ,  A61K51/04 ,  A61K103/30 ,  A61K103/40 ,  A61K103/00 ,  A61P35/00

CPC分类号： Y02P20/55 ,  A61K31/395 ,  A61K31/397 ,  A61K31/403 ,  A61K31/428 ,  A61K31/438 ,  A61K31/4725 ,  A61K31/555 ,  A61K49/00 ,  A61K51/00 ,  A61K51/04 ,  A61P35/00 ,  C07D257/02 ,  C07D403/06 ,  C07D401/06 ,  C07D417/06 ,  C07F13/00 ,  C07K5/0215

摘要： A peptide-urea derivative, a pharmaceutical composition containing same and an application thereof are provided, the derivative being as shown in formula I. The derivative can be used for preoperative imaging diagnosis and grading of PSMA-positive prostate cancer, and can also be used for the treatment of various types and stages of prostate cancer, achieving the integration of diagnosis and treatment, and having broad application prospects.